Please use this identifier to cite or link to this item:
Title: Variability of disease spectrum in children with liver phosphorylase kinase deficiency caused by mutations in the PHKG2 gene.
Austin Authors: Bali, Deeksha S;Goldstein, Jennifer L;Fredrickson, Keri;Rehder, Catherine;Boney, Anne;Austin, Stephanie;Weinstein, David A;Lutz, Richard;Boneh, Avihu;Kishnani, Priya S
Affiliation: University of Nebraska Medical Center, Munroe-Meyer Institute for Genetics & Rehabilitation, 985440 Nebraska Medical Center, USA
Department of Pediatrics, Box 103856, Duke University Health System, Durham, NC 27710, USA
Metabolic Genetics, Victorian Clinical Genetics Services, The Murdoch Children's Research Institute, Royal Children's Hospital Melbourne, Department of Paediatrics, University of Melbourne, Flemington Road, Parkville 3052, Australia
Clinical Molecular Diagnostic Laboratory, 4425 Ben Franklin Blvd, Duke University Health System, Durham, NC 27704, USA
Glycogen Storage Disease Program, PO Box 100296, University of Florida College of Medicine, Gainesville, FL 32610, USA
Issue Date: 19-Dec-2013
Publication information: Molecular Genetics and Metabolism 2013; 111(3): 309-13
Abstract: Liver phosphorylase b kinase (PhK) deficiency (glycogen storage disease type IX), one of the most common causes of glycogen storage disease, is caused by mutations in the PHKA2, PHKB, and PHKG2 genes. Presenting symptoms include hepatomegaly, ketotic hypoglycemia, and growth delay. Clinical severity varies widely. Autosomal recessive mutations in the PHKG2 gene, which cause about 10-15% of cases, have been associated with severe symptoms including increased risk of liver cirrhosis in childhood. We have summarized the molecular, biochemical, and clinical findings in five patients, age 5-16 years, diagnosed with liver PhK deficiency caused by PHKG2 gene mutations. We have identified five novel and two previously reported mutations in the PHKG2 gene in these five patients. Clinical severity was variable among these patients. Histopathological studies were performed for four of the patients on liver biopsy samples, all of which showed signs of fibrosis but not cirrhosis. One of the patients (aged 9 years) developed a liver adenoma which later resolved. All patients are currently doing well. Their clinical symptoms have improved with age and treatment. These cases add to the current knowledge of clinical variability in patients with PHKG2 mutations. Long term studies, involving follow-up of these patients into adulthood, are needed.
Gov't Doc #: 24389071
DOI: 10.1016/j.ymgme.2013.12.008
Journal: Molecular genetics and metabolism
Type: Journal Article
Subjects: Glycogen storage disease type IX
Liver adenoma
PHKG2 gene
Phosphorylase b kinase deficiency
Child, Preschool
Glycogen Storage Disease.genetics.metabolism.pathology
Phosphorylase Kinase.deficiency.genetics
Appears in Collections:Journal articles

Show full item record

Page view(s)

checked on Dec 10, 2023

Google ScholarTM


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.